Eastern Biotech Revenue and Competitors
Estimated Revenue & Valuation
- Eastern Biotech's estimated annual revenue is currently $924k per year.
- Eastern Biotech's estimated revenue per employee is $84,000
Employee Data
- Eastern Biotech has 11 Employees.
- Eastern Biotech grew their employee count by 10% last year.
Eastern Biotech's People
| Name | Title | Email/Phone |
|---|
Eastern Biotech Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 11 | 0% | N/A | N/A |
#2 | $7.4M | 59 | 7% | N/A | N/A |
#3 | $0.9M | 11 | 10% | N/A | N/A |
#4 | $36.5M | 237 | 10% | N/A | N/A |
#5 | $15.8M | 113 | 0% | N/A | N/A |
#6 | $4.1M | 37 | 0% | N/A | N/A |
What Is Eastern Biotech?
Eastern Biotech & Life Sciences based at DuBiotech, Dubai, is the first company in the Middle East to offer comprehensive genetic testing services. We have carefully examined the biotechnological horizon to identify the genetic tests most relevant to this region and offer them directly to the people of the Middle East. www.easternbiotech.com www.easternbiotech.ae www.foodintolerancetest.ae www.dnaancestry.ae www.geneticcounseling.ae www.telomeretest.ae
keywords:N/A
N/A
Total Funding
11
Number of Employees
$924k
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Eastern Biotech News
NEW YORK, April 22, 2022 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT) ... will be held on Thursday, April 28, 2022 at 12:30pm Eastern Time.
... Illumina, Thermo Fisher Scientific, Bio-Rad, Roche, Lonza, INVITAE, Genetic Technologies, Interleukin Genetics, Eastern Biotech.
... Patent Infringement Victory for Biotech Company Seagen Inc. ... the U.S. District Court for the Eastern District of Texas in Marshall.
Other Companies in Dubai
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 11 | N/A | N/A |
#2 | $1M | 11 | 0% | N/A |
#3 | $1M | 11 | 10% | N/A |
#4 | $1M | 11 | N/A | N/A |
#5 | $0.9M | 11 | 0% | N/A |